Rusnano

Rusnano has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Neophotonics Corp, Cartesian Therapeutics, Inc. and Aquantia Corp. In total, 19 filings cover trades dated from 25 September 2013 to 7 November 2017.

In open-market terms, that means 2 purchases worth €2.7M on one side and 9 sales worth €6.9M on the other. Netting one side against the other leaves €4.2M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2017 alone, the filings show no purchases and 9 sales.

Most recently, on 9 November 2017, the filings show a transaction in Aquantia Corp. The most recent open-market purchase was published on 29 June 2016, 3,784 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.